EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plant-Derived Bioactive Compounds in Gestational Diabetes Mellitus: Placental Mechanisms, Translational Evidence, and Maternal–Fetal Safety Considerations

Nazgul Zhaparkulova, Gulzhan Zhamanbayeva, Zhuldyz Zhaksybay, Madina Molsadykkyzy, Akbota Amankeldi, Gulziya Srailova, Marzhan Kulbayeva, Gulmira Tussupbekova, Zhassulan Zhaniyazov, Ilya Digel

Life · 07.11.2026 · 16 (11) · 1886

DOI: 10.3390/life16111886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 07.11.2026. Verfasst von Nazgul Zhaparkulova und 9 weiteren Autor:innen. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) is a heterogeneous metabolic disorder in which maternal dysmetabolism interacts with placental adaptation and fetal development. Plant-derived bioactive compounds have attracted interest because they modulate metabolic, inflammatory, redox, mitochondrial, nutrient-sensing, and vascular pathways implicated in GDM; however, mechanistic activity alone does not establish therapeutic suitability during pregnancy. This critical narrative review evaluates selected phytochemicals using a placenta-centered translational perspective that distinguishes evidence from women with GDM, human placental and pregnancy-associated tissues, pregnancy-specific animal models, and mechanistic cellular systems. Human placental studies demonstrate substantial heterogeneity in insulin signaling, mitochondrial function, oxidative stress, inflammation, nutrient transport, and angiogenic regulation, emphasizing that altered pathways may represent pathological, compensatory, or adaptive responses. Among the compounds reviewed, EGCG has the most direct clinical treatment evidence, whereas naringenin shows particularly strong disease-specific placental mechanistic alignment. Quercetin and mangiferin have substantial pregnancy-specific preclinical support, while resveratrol and berberine illustrate how fetal or developmental concerns can limit translation despite promising metabolic effects. Overall, no isolated phytochemical currently combines replicated clinical efficacy, defined maternal–fetal pharmacokinetics, placental relevance, and adequate developmental safety. Future translation requires integrated evaluation across the maternal–placental–fetal unit.

Zitieren

APA

Zhaparkulova, N., Zhamanbayeva, G., Zhaksybay, Z., Molsadykkyzy, M., Amankeldi, A., Srailova, G., Kulbayeva, M., Tussupbekova, G., Zhaniyazov, Z., & Digel, I. (2026). Plant-Derived Bioactive Compounds in Gestational Diabetes Mellitus: Placental Mechanisms, Translational Evidence, and Maternal–Fetal Safety Considerations. Life, 16(11), 1886. https://doi.org/10.3390/life16111886

Vancouver

Zhaparkulova N, Zhamanbayeva G, Zhaksybay Z, Molsadykkyzy M, Amankeldi A, Srailova G, et al. Plant-Derived Bioactive Compounds in Gestational Diabetes Mellitus: Placental Mechanisms, Translational Evidence, and Maternal–Fetal Safety Considerations. Life. 2026;16(11):1886. doi:10.3390/life16111886

BibTeX
@article{Zhaparkulova2026,
  author = {Zhaparkulova, Nazgul and Zhamanbayeva, Gulzhan and Zhaksybay, Zhuldyz and Molsadykkyzy, Madina and Amankeldi, Akbota and Srailova, Gulziya and Kulbayeva, Marzhan and Tussupbekova, Gulmira and Zhaniyazov, Zhassulan and Digel, Ilya},
  title = {Plant-Derived Bioactive Compounds in Gestational Diabetes Mellitus: Placental Mechanisms, Translational Evidence, and Maternal–Fetal Safety Considerations},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1886},
  doi = {10.3390/life16111886}
}
Kostenlos starten →